Prateek Mendiratta, MD, Oncology, Cleveland, OH, Duke University Hospital

PrateekMendirattaMD

OncologyCleveland, OH

Genitourinary Oncology, Hematologic Oncology

Assistant Professor in Hematology/Oncology

Dr. Mendiratta is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Mendiratta's full profile

Already have an account?

Summary

  • GU and Cutaneous Malignancies
  • Prateek Mendiratta

    ASCO Connection

    2318 Mill Road, Suite 800, Alexandria, VA 22314 | Phone 571-483-1300 | ©2018 American Society of Clinical Oncology (ASCO). All Rights Reserved Worldwide

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship
  • Duke University Hospital
    Duke University HospitalFellowship
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityResidency
  • Virginia Commonwealth University School of Medicine
    Virginia Commonwealth University School of MedicineMedicalSchool
  • Virginia Commonwealth UniversityOtherTraining

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2011 - 2020
  • NC State Medical License
    NC State Medical License 2005 - 2019
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Patient Choice Award Vitals, 2016
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • ASCO Merit Award ASCO Annual Meeting, 2008
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Genomic signatures associated with the Development, Progression, and Outcome of prostate cancer  
    Mendiratta P, Febbo, P, Molecular Diagnosis and therapy, 1/1/2007
  • Treatment of Hairy Cell Leukemia with 2-Chlorodexoyadenosine (2CdA): Long term follow-up of the Northwestern University Experience  
    Chadha P, Rademaker AW, Mendiratta P, et al, Blood, 1/1/2005

Books/Book Chapters

Abstracts/Posters

  • A Genomic Strategy for targeting therapy in Castrate-Independent Prostate Cancer
    Mendiratta P, ASCO, 1/1/2008

Lectures

  • Genomic Strategy for targeting therapy in Castrate-Independent Prostate Cancer 
    1/1/2009

Press Mentions

  • Inside Sean Parker's $250 Million Bet to Cure CancerApril 13, 2016

Professional Memberships

Hospital Affiliations